- Lobbying
- Lobbying by Future of Pharmacy Coalition LLC
Lobbying Relationship
Bills mentioned
H.R.7213: Equitable Community Access to Pharmacist Services Act
Sponsor: Ron Kind (D-Wis.)
H.R.7213: Autism Collaboration, Accountability, Research, Education, and Support...
Sponsor: Christopher H. Smith (R-N.J.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Bob Siggins | Chief of Staff, U.S. Rep. Earl Pomeroy. |
Timothy P. Trysla | Senior Policy Advisor, CMS |
Earl Pomeroy | Congressman, U.S. House of Representatives |
Elinor Hiller | Senior Advisor, Office of the Administrator, CMS; Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
James Paluskiewicz | Chief Counsel, House Health Subcommittee; Professional Staff, House Energy & Commerce Committee; Legislative Dir./Deputy Chief of Staff, Rep. Michael Burgess; Legislative Dir., Rep. Charlie Norwood; Legislative Correspondent, Rep. Tubbs Jones. |
Mark Rayder | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo. |
Jane Lucas | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, U.S. Senator John Thune. |
James Paluskiewicz | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate